Heparanase as mediator of angiogenesis: mode of action.
Elkin
M
M
Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem 91120, Israel.
Ilan
N
N
Ishai-Michaeli
R
R
Friedmann
Y
Y
Papo
O
O
Pecker
I
I
Vlodavsky
I
I
D000818:Animals; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000201:enzymology*; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D005966:Glucuronidase / Q000502:physiology*; D006497:Heparan Sulfate / Q000378:metabolism; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008934:Mitogens / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000502:physiology*; D011994:Recombinant Proteins / Q000378:metabolism; D000099175:Heparanase
D016222:Fibroblast Growth Factor 2; D005966:Glucuronidase; D006497:Heparan Sulfate; D008934:Mitogens; D011994:Recombinant Proteins; D000099175:Heparanase